Curiox Biosystems's earnings have been declining at an average annual rate of -23%, while the Life Sciences industry saw earnings declining at 3.1% annually. Revenues have been declining at an average rate of 21.4% per year.
How Curiox Biosystems makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
KOSDAQ:A445680 Revenue, expenses and earnings (KRW Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
5,555
-26,200
10,470
2,491
31 Dec 25
5,152
-27,177
10,101
2,615
30 Sep 25
4,258
-23,247
10,430
2,811
30 Jun 25
3,825
-24,236
10,576
2,901
31 Mar 25
3,922
-9,049
11,024
2,634
31 Dec 24
4,588
-8,089
11,657
2,504
30 Sep 24
5,967
-12,372
11,183
2,360
30 Jun 24
5,697
-10,904
10,982
2,223
31 Mar 24
6,224
-10,667
10,663
2,310
31 Dec 23
6,788
-10,040
10,643
2,109
30 Sep 23
7,113
-11,594
11,188
2,460
31 Mar 23
8,612
-9,957
13,101
1,834
31 Dec 22
7,237
-11,495
13,219
1,470
31 Dec 21
5,523
-14,524
10,141
460
31 Dec 20
4,384
-6,279
4,957
172
Quality Earnings: A445680 is currently unprofitable.
Growing Profit Margin: A445680 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A445680 is unprofitable, and losses have increased over the past 5 years at a rate of 23% per year.
Accelerating Growth: Unable to compare A445680's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A445680 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-26.7%).
Return on Equity
High ROE: A445680 has a negative Return on Equity (-50.66%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/06 22:50
End of Day Share Price
2026/06/05 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Curiox Biosystems Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.